Short Cuts

All you need to read in the other general journals

BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a1129 (Published 05 August 2008) Cite this as: BMJ 2008;337:a1129

Technology is not to blame for adverse perinatal outcomes in assisted conception

Singleton babies born after assisted fertilisation are at higher risk of low birth weight, preterm delivery, and perinatal death than spontaneously conceived ones. But a new study suggests that this is mainly the result of factors associated with infertility rather than the technology itself.

A Norwegian population based cohort study, which compared perinatal outcomes in more than 1 200 000 singletons born as a result of spontaneous conception and more than 8000 singletons born after assisted conception, found that those born after assisted conception were lighter at birth (difference 25 g, 95% CI 14 to 35), had shorter duration of gestation (2.0 days, 1.6 to 2.3), and had an increased risk of perinatal death (odds ratio 1.31, 1.05 to 1.65) and being small for gestational age (1.26, 1.10 to 1.44).

However, when the researchers compared babies born to 2546 women who, in consecutive pregnancies, gave birth to a singleton after assisted conception and after spontaneous conception, they found that outcomes differed little (difference in birth weight 9 g, −18 to 36; gestational age 0.6 days, −0.5 to 1.7; and odds ratio for small for gestational age 0.99, 0.62 to 1.57). Babies born after assisted conception even had a lower risk of perinatal death (0.36, 0.20 to 0.67).

Ciclosporin reduces myocardial reperfusion injury

A pilot study tested a hypothesis that because ciclosporin inhibits the opening of the mitochondrial permeability transition pores, it might attenuate myocardial reperfusion injury, which in patients with myocardial infarction accounts for up to a half of the final size of the infarct. Fifty eight people with acute ST elevation myocardial infarction were randomised to an intravenous bolus of 2.5 mg of ciclosporin per kg of body weight, or saline, before undergoing percutaneous coronary intervention.

Ciclosporin significantly reduced the release of creatine kinase (P=0.04) and lowered troponin I, although not significantly …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe